| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
epidermal growth factor receptor pathway substrate 15 like 1 | 0.743 | 0.385 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 3 | 4 | 2011 | 2018 | ||||||||
|
major histocompatibility complex, class I, B | 0.379 | 0.885 | 3.9E-05 |
|
phenotype | 0.100 | None | 1.000 | 3 | 3 | 2011 | 2017 | ||||||||
|
IKAROS family zinc finger 3 | 0.608 | 0.692 | 0.98 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2016 | 2018 | ||||||||
|
tet methylcytosine dioxygenase 2 | 0.458 | 0.808 | 4.3E-54 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2016 | 2018 | ||||||||
|
long intergenic non-protein coding RNA 1934 | 0.821 | 0.308 |
|
phenotype | 0.100 | None | 1.000 | 2 | 3 | 2016 | 2018 | |||||||||
|
acyl-CoA oxidase like | 0.674 | 0.577 | 5.2E-15 |
|
phenotype | 0.100 | None | 1.000 | 1 | 2 | 2016 | 2016 | ||||||||
|
solute carrier family 47 member 1 | 0.729 | 0.462 | 2.0E-14 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
protein phosphatase 2 regulatory subunit B''gamma | 0.700 | 0.538 | 6.8E-09 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
PIN2 (TERF1) interacting telomerase inhibitor 1 | 0.587 | 0.692 | 4.6E-09 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
protein kinase AMP-activated catalytic subunit alpha 2 | 0.456 | 0.846 | 3.5E-08 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | ||||||||
|
Rho GTPase activating protein 15 | 0.682 | 0.462 | 1.4E-08 |
|
phenotype | 0.100 | None | 1.000 | 1 | 2 | 2016 | 2016 | ||||||||
|
phosphoribosyl transferase domain containing 1 | 0.805 | 0.385 | 2.4E-13 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
chromosome 1 open reading frame 147 | 1.8E-02 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||||
|
MTOR associated protein, eak-7 homolog | 0.931 | 0.154 | 9.8E-18 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
protein tyrosine phosphatase receptor type C | 0.435 | 0.808 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
Pvt1 oncogene | 0.495 | 0.731 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | |||||||||
|
RNA binding motif single stranded interacting protein 1 | 0.861 | 0.231 | 0.12 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
peroxisome proliferator activated receptor delta | 0.513 | 0.846 | 0.99 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
POU class 5 homeobox 1 | 0.441 | 0.846 | 0.95 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
IRF1 antisense RNA 1 | 0.670 | 0.385 | 4.2E-03 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
methylenetetrahydrofolate dehydrogenase, cyclohydrolase and formyltetrahydrofolate synthetase 1 | 0.554 | 0.769 | 4.5E-03 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
arginine-glutamic acid dipeptide repeats | 0.526 | 0.846 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
NFKB inhibitor alpha | 0.487 | 0.885 | 0.99 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
ninjurin 2 | 0.751 | 0.269 | 1.1E-03 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
ATPase plasma membrane Ca2+ transporting 4 | 0.659 | 0.577 | 1.5E-03 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 |